Medicalised Homecare

 

Remote patient monitoring can cut chronic disease care costs by 40% — an interview with Lasse Rousi, Medixine 

Over the coming years and decades an increasing amount of care will be delivered to patients in their homes. New devices and wearables that can collect health data from people whilst they’re at home and healthcare’s digitalisation trend are opening up new possibilities, both for prevention and for providing better and more efficient care to those with chronic conditions. 

Healthcare investment “through the bottom of the cycle” — Goldberg (Rothschild)

At last year’s conference Hedley Goldberg, Managing Director at multinational investment bank Rothschild, predicted healthcare M&A activity would begin picking up again in Q4 2023 or Q1 2024. But we’re now halfway through 2024 and there are still very few deals above €500m taking place. Goldberg is confident, however, that we have now passed through the bottom of the cycle.

Clariane exploring French homecare business disposal options

Pan-European listed French nursing home group Clariane is exploring disposal options for its Hospitalisation à Domicile and Services de Soins Infirmiers à Domicile (HAD/SSIAD) business in France with the members of the Comité Social et Economique Central d'Entreprise (CSEC).

Attendo increases market share in Sweden with 120 Team Olivia units

Pan-Nordic care group Attendo has acquired 120 facilities from Team Olivia, a rival Nordic care group. The acquisition will boost Attendo's already-dominant market share in Sweden’s for-profit disability, personal and family, and home care sectors. We speak to the company’s investor relations director to find out more. 

Interview: Kelly Hudson, Chief Strategy Officer, Lilli

The opportunities afforded by advances in technology to assist with caring for the elderly are huge, but much of the focus remains on reactive tools. HBI speaks to Kelly Hudson, chief strategy officer of UK remote technology company Lilli to hear why the focus needs to be more on proactive solutions.

HBI 2023: Healthcare regulation – opportunities and risks

Regulatory changes are one of the major concerns among players in healthcare services. A busy panel of lawyers, operators and investors considered this thorny issue at HBI 2023, with a general feeling that even the strictest of regulations can provide some kind of opportunity, and that private funding is so essential a component in health care today, it cannot be legislated away.

Humana wins appeal against licence revocation

Pan-Nordic care company Humana Group has succeeded with an appeal against the decision by Sweden's health care inspectorate to revoke its licence. The company's share price shot up 48% after the announcement.

17 things we learned at HBI 2023: Our key insights and takeaways

Our annual conference took place earlier this week in London. Over a jam-packed three days of HBI 2023, an impressive array of delegates from across Europe and beyond gathered in the heart of London and shared their insights into the myriad challenges and abundant opportunities the sector faces, and offered their views on how some of them might be addressed. Here are some of our key takeaways.

Find Us